Emergent BioSolutions Inc. | TalkMarkets | Page 1
No data available
No data available

People who follow this stock (41)

Latest Tweets for $EBS

No tweets yet!

PARTNER HEADLINES

$EBS

Dow Bounces Back With A 350-Point Pop As Tech Drags Nasdaq
Old Time Investor 10/31/2025 12:33:06 AM
$EBS has just raised FY25 EBITDA guidance to a conservative $195m-$210m. As the lower end of this range has already been reached in the first nine months, and with an excellent Q4 expected (based on confirmed orders), $EBS should achieve $220m EBITDA in 2025. We are now forecasting $250m+ EBITDA in 2026. With a market cap of only $530m, $EBS should re-rate quickly from $10 to $20-$30. $EBS share price target (short term): $20 $EBS share price target (12 months): $30 $EBS: Strong Buy. Bullish
Wednesday's Rally Followed By Friday's
Andrew Armstrong 11/11/2024 3:12:00 PM
$EBS share price target raised to $60 (current sp $12). Following the 1270% earnings beat (see video below), we've increased $EBS share price target to $60. The $60 share price target for $EBS is based on FY25 eps of $4 and PE of 15. $EBS Strong Buy with 400% upside to $60 share price target. This short video provides a good overview of $EBS Q3 2024 earnings, including massive 1270% earnings beat... https://www.youtube.com/watch?v=-7MAeIihqco
1 to 2 of 2 comments